Cargando…

Basal hypersecretion of glucagon and insulin from palmitate-exposed human islets depends on FFAR1 but not decreased somatostatin secretion

In obesity fasting levels of both glucagon and insulin are elevated. In these subjects fasting levels of the free fatty acid palmitate are raised. We have demonstrated that palmitate enhances glucose-stimulated insulin secretion from isolated human islets via free fatty acid receptor 1 (FFAR1/GPR40)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kristinsson, H., Sargsyan, E., Manell, H., Smith, D. M., Göpel, S. O., Bergsten, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498543/ https://www.ncbi.nlm.nih.gov/pubmed/28680093 http://dx.doi.org/10.1038/s41598-017-04730-5

Ejemplares similares

Combined lipidomic and proteomic analysis of isolated human islets exposed to palmitate reveals time-dependent changes in insulin secretion and lipid metabolism
por: Roomp, Kirsten, et al.
Publicado: (2017)

GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans
por: Stone, Virginia M., et al.
Publicado: (2014)

Reduced somatostatin signalling leads to hypersecretion of glucagon in mice fed a high-fat diet
por: Kellard, Joely A., et al.
Publicado: (2020)

Long-term exposure of mouse pancreatic islets to oleate or palmitate results in reduced glucose-induced somatostatin and oversecretion of glucagon
por: Collins, S. C., et al.
Publicado: (2008)

Identification of early biological changes in palmitate-treated isolated human islets
por: Sargsyan, Ernest, et al.
Publicado: (2018)

Regulating Glucagon Secretion: Somatostatin in the Spotlight
por: Rutter, Guy A.
Publicado: (2009)

Small Mouse Islets Are Deficient in Glucagon-Producing Alpha Cells but Rich in Somatostatin-Secreting Delta Cells
por: Lau, Joey, et al.
Publicado: (2016)

Metformin Can Attenuate Beta-Cell Hypersecretion—Implications for Treatment of Children with Obesity
por: Wen, Quan, et al.
Publicado: (2023)

Misrouting of glucagon and stathmin-2 towards lysosomal system of α-cells in glucagon hypersecretion of diabetes
por: Asadi, Farzad, et al.
Publicado: (2021)

The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice
por: Ørgaard, Anne, et al.
Publicado: (2017)

Glucose, adrenaline and palmitate antagonistically regulate insulin and glucagon secretion in human pseudoislets
por: Lorza-Gil, Estela, et al.
Publicado: (2019)

Fatty acids stimulate insulin secretion from human pancreatic islets at fasting glucose concentrations via mitochondria-dependent and -independent mechanisms
por: Cen, Jing, et al.
Publicado: (2016)

Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion
por: Vergari, Elisa, et al.
Publicado: (2019)

Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2
por: Tolhurst, Gwen, et al.
Publicado: (2012)

Intra-islet glucagon secretion and action in the regulation of glucose homeostasis
por: Wang, Qinghua, et al.
Publicado: (2013)

In vivo studies of glucagon secretion by human islets transplanted in mice
por: Tellez, Krissie, et al.
Publicado: (2020)

Somatostatin Secreted by Islet δ-Cells Fulfills Multiple Roles as a Paracrine Regulator of Islet Function
por: Hauge-Evans, Astrid C., et al.
Publicado: (2009)

UPR in palmitate-treated pancreatic beta-cells is not affected by altering oxidation of the fatty acid
por: Sargsyan, Ernest, et al.
Publicado: (2011)

Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease
por: Fabisiak, Adam, et al.
Publicado: (2020)

A FFAR1 full agonist restores islet function in models of impaired glucose-stimulated insulin secretion and diabetic non-human primates
por: Rady, Brian, et al.
Publicado: (2022)

Lipotoxicity is glucose-dependent in INS-1E cells but not in human islets and MIN6 cells
por: Sargsyan, Ernest, et al.
Publicado: (2011)

A Variation on the Theme: SGLT2 Inhibition and Glucagon Secretion in Human Islets
por: Hodson, David J., et al.
Publicado: (2020)

Palmitate Impairs and Eicosapentaenoate Restores Insulin Secretion Through Regulation of SREBP-1c in Pancreatic Islets
por: Kato, Toyonori, et al.
Publicado: (2008)

ULTRASTRUCTURE OF THE A-CELLS OF CAT ISLETS OF LANGERHANS FOLLOWING SYMPATHETIC STIMULATION OF GLUCAGON SECRETION
por: Esterhuizen, A. C., et al.
Publicado: (1970)

Abnormal regulation of glucagon secretion by human islet alpha cells in the absence of beta cells
por: Liu, Wei, et al.
Publicado: (2019)

A microfluidic system for monitoring glucagon secretion from human pancreatic islets of Langerhans
por: Eaton, Wesley J., et al.
Publicado: (2021)

FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing
por: Ang, Zhiwei, et al.
Publicado: (2018)

Molecular characterization of free fatty acid receptors FFAR2 and FFAR3 in the domestic cat
por: Yamamoto, Ichiro, et al.
Publicado: (2020)

Establishment of a Refined Oral Glucose Tolerance Test in Pigs, and Assessment of Insulin, Glucagon and Glucagon-Like Peptide-1 Responses
por: Manell, Elin, et al.
Publicado: (2016)

Dapagliflozin stimulates glucagon secretion at high glucose: experiments and mathematical simulations of human A-cells
por: Pedersen, Morten Gram, et al.
Publicado: (2016)

Discovery of ciliary G protein-coupled receptors regulating pancreatic islet insulin and glucagon secretion
por: Wu, Chien-Ting, et al.
Publicado: (2021)

Glucagon-like peptide-1 receptor blockade impairs islet secretion and glucose metabolism in humans
por: Welch, Andrew A., et al.
Publicado: (2023)

In Situ Electrophysiological Examination of Pancreatic α Cells in the Streptozotocin-Induced Diabetes Model, Revealing the Cellular Basis of Glucagon Hypersecretion
por: Huang, Ya-Chi, et al.
Publicado: (2013)

Proteins altered by elevated levels of palmitate or glucose implicated in impaired glucose-stimulated insulin secretion
por: Sol, E-ri M, et al.
Publicado: (2009)

Palmitate is not an effective fuel for pancreatic islets and amplifies insulin secretion independent of calcium release from endoplasmic reticulum
por: Kuok, Iok Teng, et al.
Publicado: (2019)

Glucose inhibits glucagon secretion by decreasing [Ca(2+)](c) and by reducing the efficacy of Ca(2+) on exocytosis via somatostatin-dependent and independent mechanisms
por: Singh, Bilal, et al.
Publicado: (2022)

Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa
por: Maiza, Jean Christophe, et al.
Publicado: (2007)

Optimization of First-in-Class Dual-Acting FFAR1/FFAR4 Allosteric Modulators with Novel Mode of Action
por: Lückmann, Michael, et al.
Publicado: (2022)

20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1
por: Tunaru, Sorin, et al.
Publicado: (2018)

Leucine suppresses glucagon secretion from pancreatic islets by directly modulating α-cell cAMP
por: Knuth, Emily R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d473kdeb69v3j9dt9v671arcd7